NCT02265484View on ClinicalTrials.gov

To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Cirrhosis Related Parkinsonism
Interventions
DRUG

Lactulose+Rifaximin +Bromocriptine

Trial Locations (1)

110070

Institute of Liver & Biliary Sciences, New Delhi

All Listed Sponsors
lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02265484 - To Study the Efficacy of Bromocriptine in Patients With Hepatic/Cirrhosis Related Parkinsonism | Biotech Hunter | Biotech Hunter